Open Access

Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor

  • Authors:
    • Mamdooh Ghoneum
    • Nariman K. Badr El-Din
    • Ashraf Z. Mahmoud
    • Lucilene Tolentino
    • Deyu Pan
    • Tahia Ali Hassan
  • View Affiliations

  • Published online on: April 10, 2019     https://doi.org/10.3892/or.2019.7107
  • Pages: 3155-3166
  • Copyright: © Ghoneum et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Baker's yeast, Saccharomyces cerevisiae, has been shown to sensitize a variety of breast cancer cell (BCC) lines to paclitaxel chemotherapy in vitro. The present study evaluated the ability of S. cerevisiae to sensitize BCCs to paclitaxel in animals bearing Ehrlich ascites carcinoma (EAC). Mice bearing EAC were intratumorally injected with dead S. cerevisiae (1x107 cells/ml) in the presence or absence of low- and high-dose paclitaxel [paclitaxel-L, 2 mg/kg body weight (BW) and paclitaxel-H, 10 mg/kg BW, respectively]. At 30 days post tumor inoculation, co-treatment with yeast plus paclitaxel-L showed improvements over paclitaxel-H alone, as measured by tumor weight (-64 vs. -53%), DNA damage (+79 vs. +62%), tumor cell apoptosis (+217 vs. +177%), cell proliferation (-56 vs. -42%) and Ki-67 marker (+95 vs. +40%). Histopathology and ultra-structural examinations showed that yeast plus paclitaxel-L enhanced apoptosis in EAC more than paclitaxel-H alone and caused comparable tumor necrosis. We conclude that baker's yeast may be used with low-dose chemotherapy to achieve the same potency as high-dose chemotherapy in mice bearing EAC. This suggests that baker's yeast may be an anticancer adjuvant and may have clinical implications for the treatment of breast cancer.

References

1 

Gligorov J and Lotz JP: Preclinical pharmacology of the taxanes: Implications of the differences. Oncologist. 9 (Suppl 2):3–8. 2004. View Article : Google Scholar : PubMed/NCBI

2 

Guastalla JP, Lhommé C, Dauplat J, Namer M, Bonneterre J, Oberling F, Pouillart P, Fumoleau P, Kerbrat P, Tubiana N, et al: Taxol (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma: An interim analysis of a phase II multicenter study. Ann Oncol. 5 (Suppl 6):S33–S38. 1994.PubMed/NCBI

3 

Ohtsu T, Sasaki Y, Tamura T, Miyata Y, Nakanomyo H, Nishiwaki Y and Saijo N: Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion. Clin Cancer Res. 1:599–606. 1995.PubMed/NCBI

4 

Newman DJ, Cragg GM and Snader KM: Natural products as sources of new drugs over the period 1981–2002. J Nat Prod. 66:1022–1037. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Sylvester PW, Kaddoumi A, Nazzal S and El Sayed KA: The value of tocotrienols in the prevention and treatment of cancer. J Am Coll Nutr. 29 (Suppl):324S–333S. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Chen YJ: Potential role of tetrandrine in cancer therapy. Acta Pharmacol Sin. 23:1102–1106. 2002.PubMed/NCBI

7 

Farina HG, Pomies M, Alonso DF and Gomez DE: Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep. 16:885–891. 2006.PubMed/NCBI

8 

Rafieian-Kopaei M and Movahedi M: Breast cancer chemopreventive and chemotherapeutic effects of Camellia Sinensis (green tea): An updated review. Electron Physician. 9:3838–3844. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Badr El-Din NK, Noaman E and Ghoneum M: In vivo tumor inhibitory effects of nutritional rice bran supplement MGN-3/Biobran on Ehrlich carcinoma-bearing mice. Nutr Cancer. 60:235–244. 2008. View Article : Google Scholar : PubMed/NCBI

10 

Badr El-Din NK, Abdel Fattah SM, Pan D, Tolentino L and Ghoneum M: Chemopreventive activity of MGN-3/Biobran against chemical induction of glandular stomach carcinogenesis in rats and its apoptotic effect in gastric cancer cells. Integr Cancer Ther. 15:NP26–NP34. 2016. View Article : Google Scholar : PubMed/NCBI

11 

Pérez-Martínez A, Valentín J, Fernández L, Hernández-Jiménez E, López-Collazo E, Zerbes P, Schwörer E, Nuñéz F, Martín IG, Sallis H, et al: Arabinoxylan rice bran (MGN-3/Biobran) enhances natural killer cell-mediated cytotoxicity against neuroblastoma in vitro and in vivo. Cytotherapy. 17:601–612. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Ghoneum M and Gollapudi S: Susceptibility of the human LNCaP prostate cancer cells to the apoptotic effect of marina crystal minerals (MCM) in vitro. Oncol Rep. 22:155–159. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Ghoneum M, Seto Y, Sato S, Ghoneum A, Braga M and Gollapudi S: Gross thymic extract, Thymax, induces apoptosis in human breast cancer cells in vitro through the mitochondrial pathway. Anticancer Res 28 (3A). 1603–1609. 2008.

14 

Ghoneum M and Gimzewski J: Apoptotic effect of a novel kefir product, PFT, on multidrug-resistant myeloid leukemia cells via a hole-piercing mechanism. Int J Oncol. 44:830–837. 2014. View Article : Google Scholar : PubMed/NCBI

15 

Gollapudi S and Ghoneum M: MGN-3/Biobran, modified arabinoxylan from rice bran, sensitizes human breast cancer cells to chemotherapeutic agent, daunorubicin. Cancer Detect Prev. 32:1–6. 2008. View Article : Google Scholar : PubMed/NCBI

16 

Ghoneum M: Wheat and rice in disease prevention and health. In: Apoptosis and Arabinoxylan Rice Bran. Watson RR, Preedy V and Zibadi S: Elsevier Science & Technology Book; pp. 399–404. 2014

17 

Endo Y and Kanbayashi H: Modified rice bran beneficial for weight loss of mice as a major and acute adverse effect of Cisplatin. Pharmacol Toxicol. 92:300–303. 2003. View Article : Google Scholar : PubMed/NCBI

18 

Jacoby HI, Wnorowski G, Sakata K and Maeda H: The effect of MGN-3 on cisplatin and doxorubicin induced toxicity in the rat. J. Nutraceuticals Funct Med Foods. 3:3–11. 2001. View Article : Google Scholar

19 

Bang MH, Van Riep T, Thinh NT, Song H, Dung TT, Van Truong L, Van Don L, Ky TD, Pan D, Shaheen M, et al: Arabinoxylan rice bran (MGN-3) enhances the effects of interventional therapies for the treatment of hepatocellular carcinoma: A three-year randomized clinical trial. Anticancer Res. 30:5145–5151. 2010.PubMed/NCBI

20 

Goel A and Aggarwal BB: Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutr Cancer. 62:919–930. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Limtrakul P: Curcumin as chemosensitizer. Adv Exp Med Biol. 595:269–300. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Rege BD, Kao JP and Polli JE: Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci. 16:237–246. 2002. View Article : Google Scholar : PubMed/NCBI

23 

Tian H and Pan QC: A comparative study on effect of two bisbenzylisoquinolines, tetrandrine and berbamine, on reversal of multidrug resistance. Yao Xue Xue Bao. 32:245–250. 1997.(In Chinese). PubMed/NCBI

24 

Choi SU, Park SH, Kim KH, Choi EJ, Kim S, Park WK, Zhang YH, Kim HS, Jung NP and Lee CO: The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. Anticancer Drugs. 9:255–261. 1998. View Article : Google Scholar : PubMed/NCBI

25 

Chen C, Zhou J and Ji C: Quercetin: A potential drug to reverse multidrug resistance. Life Sci. 87:333–338. 2010. View Article : Google Scholar : PubMed/NCBI

26 

Ghoneum M and Gollapudi S: Induction of apoptosis in breast cancer cells by Saccharomyces cerevisiae, the bakers yeast, in vitro. Anticancer Res 24 (3a). 1455–1463. 2004.

27 

Ghoneum M and Gollapudi S: Modified arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced apoptosis in human breast cancer cells in vitro. Anticancer Res 25 (2A). 859–870. 2005.

28 

Ghoneum M and Gollapudi S: Synergistic role of arabinoxylan rice bran (MGN-3/Biobran) in S. cerevisiae-induced apoptosis of monolayer breast cancer MCF-7 cells. Anticancer Res 25 (6B). 4187–4196. 2005.

29 

Ghoneum M, Hamilton J, Brown J and Gollapudi S: Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the bakers yeast, in vitro. Anticancer Res 25 (2A). 981–989. 2005.

30 

Ghoneum M, Brown J and Gollapudi S: ‘Yeast therapy for the treatment of cancer and its enhancement by MGN-3/Biobran, an arabinoxylan rice bran’ in apoptosis review. Nova Science Publishers Inc.; Hauppague, NY: pp. 185–200. 2007

31 

Ghoneum M, Wang L, Agrawal S and Gollapudi S: Yeast therapy for the treatment of breast cancer: A nude mice model study. In Vivo. 21:251–258. 2007.PubMed/NCBI

32 

Ghoneum M, Badr El-Din NK, Noaman E and Tolentino L: Saccharomyces cerevisiae, the Bakers Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice. Cancer Immunol Immunother. 57:581–592. 2008. View Article : Google Scholar : PubMed/NCBI

33 

Yarkoni E, Lederer E and Rapp HJ: Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate. Infect Immun. 32:273–276. 1981.PubMed/NCBI

34 

Badr El-Din NK, Mahmoud AZ, Hassan TA and Ghoneum M: Bakers yeast sensitizes metastatic breast cancer cells to paclitaxel in vitro. Integr Cancer Ther. 17:542–550. 2018. View Article : Google Scholar : PubMed/NCBI

35 

Calixto-Campos C, Zarpelon AC, Corrêa M, Cardoso RD, Pinho-Ribeiro FA, Cecchini R, Moreira EG, Crespigio J, Bernardy CC, Casagrande R, et al: The Ehrlich tumor induces pain-like behavior in mice: A novel model of cancer pain for pathophysiological studies and pharmacological screening. BioMed Res Int. 2013:6248152013. View Article : Google Scholar : PubMed/NCBI

36 

Ehrlich and Apolant. Beobachtungen Über Maligne Mausentumoren, . Berlin: Klin Wochenschr; 28. pp. 871–874. 1905, (In German).

37 

Kaleoğlu Ö and İşli N: Ehrlich -Lettre Asit Tümörü. Tip Fak Mecm. 40:978–984. 1977.(In Turkish).

38 

Mishra S, Tamta AK, Sarikhani M, Desingu PA, Kizkekra SM, Pandit AS, Kumar S, Khan D, Raghavan SC and Sundaresan NR: Subcutaneous Ehrlich ascites carcinoma mice model for studying cancer-induced cardiomyopathy. Sci Rep. 8:55992018. View Article : Google Scholar : PubMed/NCBI

39 

Cattoretti G, Becker MH, Key G, Duchrow M, Schlüter C, Galle J and Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 168:357–363. 1992. View Article : Google Scholar : PubMed/NCBI

40 

Reynolds ES: The use of lead citrate at high pH as an electron microscopy. J Cell Biol. 17:208–212. 1963. View Article : Google Scholar : PubMed/NCBI

41 

Marupudi NI, Han JE, Li KW, Renard VM, Tyler BM and Brem H: Paclitaxel: A review of adverse toxicities and novel delivery strategies. Expert Opin Drug Saf. 6:609–621. 2007. View Article : Google Scholar : PubMed/NCBI

42 

Gustafson DL, Long ME, Zirrolli JA, Duncan MW, Holden SN, Pierson AS and Eckhardt SG: Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay. Cancer Chemother Pharmacol. 52:159–166. 2003. View Article : Google Scholar : PubMed/NCBI

43 

Xu G, Pan J, Martin C and Yeung S-CJ: Angiogenesis inhibition in the in vivo antineoplastic effect of manumycin and paclitaxel against anaplastic thyroid carcinoma. J Clin Endocrinol Metab. 86:1769–1777. 2001. View Article : Google Scholar : PubMed/NCBI

44 

Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di Gesù G and De Maria R: Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res. 63:6784–6790. 2003.PubMed/NCBI

45 

Piñeiro D, Martín ME, Guerra N, Salinas M and González VM: Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells. Exp Cell Res. 313:369–379. 2007. View Article : Google Scholar : PubMed/NCBI

46 

Potemski P and Płuzańska A: Pharmacological action of paclitaxel. Pol Merkur Lekarski. 6:27–29. 1999.(In Polish). PubMed/NCBI

47 

Badr El-Din NK, Ali DA, Alaa El-Dein M and Ghoneum M: Enhancing the apoptotic effect of a low dose of paclitaxel on tumor cells in mice by arabinoxylan rice bran (MGN-3/Biobran). Nutr Cancer. 68:1010–1020. 2016. View Article : Google Scholar : PubMed/NCBI

48 

Ghoneum M, Matsuura M, Braga M and Gollapudi S: S. cerevisiae induces apoptosis in human metastatic breast cancer cells by altering intracellular Ca2+ and the ratio of Bax and Bcl-2. Int J Oncol. 33:533–539. 2008.PubMed/NCBI

49 

Jordan MA and Wilson L: The use and action of drugs in analyzing mitosis. Methods Cell Biol. 61:267–295. 1999. View Article : Google Scholar : PubMed/NCBI

50 

Morse DL, Gray H, Payne CM and Gillies RJ: Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells. Mol Cancer Ther. 4:1495–1504. 2005. View Article : Google Scholar : PubMed/NCBI

51 

Ghoneum M, Badr El-Din NK, Ali DA and El-Dein MA: Modified arabinoxylan from rice bran, MGN-3/biobran, sensitizes metastatic breast cancer cells to paclitaxel in vitro. Anticancer Res. 34:81–87. 2014.PubMed/NCBI

52 

Yu XJ, Sun K, Tang XH, Zhou CJ, Sun H, Yan Z, Fang L, Wu HW, Xie YK and Gu B: Harmine combined with paclitaxel inhibits tumor proliferation and induces apoptosis through down-regulation of cyclooxygenase-2 expression in gastric cancer. Oncol Lett. 12:983–988. 2016. View Article : Google Scholar : PubMed/NCBI

53 

Gonçalves A, Braguer D, Carles G, André N, Prevôt C and Briand C: Caspase-8 activation independent of CD95/CD95-L interaction during paclitaxel-induced apoptosis in human colon cancer cells (HT29-D4). Biochem Pharmacol. 60:1579–1584. 2000. View Article : Google Scholar : PubMed/NCBI

54 

Peng ZG, Liu DC, Yao YB, Feng XL, Huang X, Tang YL, Yang J and Wang XX: Paclitaxel induces apoptosis in leukemia cells through a JNK activation-dependent pathway. Genet Mol Res. 15:150139042016. View Article : Google Scholar : PubMed/NCBI

55 

Varbiro G, Veres B, Gallyas F Jr and Sumegi B: Direct effect of Taxol on free radical formation and mitochondrial permeability transition. Free Radic Biol Med. 31:548–558. 2001. View Article : Google Scholar : PubMed/NCBI

56 

Roy M and Mukherjee S: Reversal of resistance towards cisplatin by curcumin in cervical cancer cells. Asian Pac J Cancer Prev. 15:1403–1410. 2014. View Article : Google Scholar : PubMed/NCBI

57 

Abulrob AN, Mason M, Bryce R and Gumbleton M: The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance. J Drug Target. 8:247–256. 2000. View Article : Google Scholar : PubMed/NCBI

58 

Gelsomino G, Corsetto PA, Campia I, Montorfano G, Kopecka J, Castella B, Gazzano E, Ghigo D, Rizzo AM and Riganti C: Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol Cancer. 12:1372013. View Article : Google Scholar : PubMed/NCBI

59 

Elwakkad A, Ghoneum M, El-sawi M, Mohamed SI, Gamal el Din AA, Pan D and Elqattan GM: Bakers yeast induces apoptotic effects and histopathological changes on skin tumors in mice. Cogent Med. 5:14376732018. View Article : Google Scholar

60 

Fahrig R: Development of host-mediated mutagenicity tests-yeast systems. II. Recovery of yeast cells out of testes, liver, lung, and peritoneum of rats. Mutat Res. 31:381–394. 1975. View Article : Google Scholar : PubMed/NCBI

61 

Frezza D, Zeiger E and Gupta BN: The intrasanguineous host-mediated assay procedure distribution and retention of yeast in the mouse. Mutat Res. 64:295–305. 1979. View Article : Google Scholar : PubMed/NCBI

62 

Maejima K, Shimoda K, Morita C, Fujiwara T and Kitamura T: Colonization and pathogenicity of Saccharomyces cerevisiae, MC16, in mice and cynomolgus monkeys after oral and intravenous administration. Jpn J Med Sci Biol. 33:271–276. 1980. View Article : Google Scholar : PubMed/NCBI

63 

Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B and Forse RA: Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Ann Surg. 220:601–609. 1994. View Article : Google Scholar : PubMed/NCBI

64 

Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P and Benotti P: A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Arch Surg. 129:1204–1210. 1994. View Article : Google Scholar : PubMed/NCBI

65 

Wanke B and Londero AT: Epidemiology and paracoccidioidomycosis infection. Paracoccidioidomycosis. Franco M, Lacaz CS, Restrepo-Moreno A and Del Negro G: CRC Press; Boca Raton: pp. 109–120. 1994

66 

Meira DA, Pereira PC, Marcondes-Machado J, Mendes RP, Barraviera B, Pellegrino Júnior J, Rezkallah-Iwasso MT, Peracoli MT, Castilho LM, Thomazini I, et al: The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis. Am J Trop Med Hyg. 55:496–503. 1996. View Article : Google Scholar : PubMed/NCBI

67 

Costa G and Holland JF: Effects of Krebs-2 carcinoma on the lipide metabolism of male Swiss mice. Cancer Res. 22:1081–1083. 1962.PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 41 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Ghoneum, M., Badr El-Din, N.K., Mahmoud, A.Z., Tolentino, L., Pan, D., & Hassan, T.A. (2019). Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor. Oncology Reports, 41, 3155-3166. https://doi.org/10.3892/or.2019.7107
MLA
Ghoneum, M., Badr El-Din, N. K., Mahmoud, A. Z., Tolentino, L., Pan, D., Hassan, T. A."Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor". Oncology Reports 41.6 (2019): 3155-3166.
Chicago
Ghoneum, M., Badr El-Din, N. K., Mahmoud, A. Z., Tolentino, L., Pan, D., Hassan, T. A."Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor". Oncology Reports 41, no. 6 (2019): 3155-3166. https://doi.org/10.3892/or.2019.7107